Baylor Genetics’ Presentations at the National Society for Genetic Counselors’ 2024 Annual Meeting Highlight How Genetic Testing Can End the Diagnostic Odyssey
Houston, Texas, September 9, 2024 – Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, will participate in the “This or That? Debating the Role of Panels, Exomes, and Genomes in the Diagnostic Odyssey” Educational Breakout Session (EBS), and will present two posters at the upcoming National Society for Genetic Counselors’ (NSGC) 2024 Annual Meeting taking place September 17 – 21, 2024 at the New Orleans Ernest N. Morial Convention Center in New Orleans, LA. Baylor Genetics will also be exhibiting in booth 427.
Dr. Christine Eng, Baylor Genetics’ Chief Medical Officer and Chief Quality Officer, will serve as a lecturer on the “This or That? Debating the Role of Panels, Exomes, and Genomes in the Diagnostic Odyssey” EBS. Arpita Neogi, MS, CGC, will moderate the session, and present two posters on behalf of the company, titled “More than an extra chromosome: Multiple diagnoses in patients with Down syndrome and severe neurological burden” and “Resolving the diagnostic odyssey in a patient with MNGIE and ring chromosome 22”. More information on the posters is detailed below.
“Individuals with genetic diseases often face a challenging diagnostic odyssey due to factors like clinical overlap, access barriers, and knowledge gaps. Advances in genomic technologies have the potential to improve research and diagnosis, navigating the ever-evolving landscape remains complex,” said Dr. Eng. “We are pleased for the opportunity to delve into these topics with our esteemed colleagues and peers from across the genetic counseling landscape at NSGC’s annual conference.”
Incorporating lecture and debate, the EBS will explore applications of gene panels, exome sequencing, genome sequencing, and will highlight current and new collaborative initiatives to increase access to genomic medicine across diverse patient populations. Using case examples as well as published and novel data, Dr. Eng and speakers from various organizations will (1) illustrate the benefits, limitations, and utility of each technology (2) identify patient, provider, payor, and policy-level barriers to accessing genomic care, (3) provide a practical framework for evaluating test utility, and (4) examine the role of genetic counselors in implementing equitable access to patient-centered care across different settings. This session will take place on Thursday, September 19 from 11:00 AM – 12:30 PM CDT in the exhibit hall and will also be streamed for those with a virtual access pass.
Title |
Presenter |
Date / Time / Location |
More than an extra chromosome: Multiple diagnoses in patients with Down syndrome and severe neurological burden |
Arpita Neogi, MS, CGC, |
Exhibit Hall // September 18 // 5:45 – 7:00 PM (CDT) |
Resolving the diagnostic odyssey in a patient with MNGIE and ring chromosome 22 |
Arpita Neogi, MS, CGC,
|
Exhibit Hall // September 19 // 4:30 – 6:30 PM (CDT) |
Registration for the event is now open.
About Baylor Genetics
As a pioneer of precision medicine for over 45 years, Baylor Genetics is a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, including Whole Genome Sequencing, Whole Exome Sequencing, and focused panels. Through a joint venture of H.U. Group Holdings, Inc. and Baylor College of Medicine, Baylor Genetics combines rapid and comprehensive precision diagnostics options with the support of genetic counselors to help clinicians avoid a lengthy diagnostic odyssey for their patients, guide medical management, and ensure no patient with a genetic disorder gets left behind. Baylor Genetics’ testing menu covers family planning, pregnancy, neonatal and pediatric testing, oncology, and many other specialized testing options. Located in Houston’s Texas Medical Center, Baylor Genetics serves clients in 50 states and 16 countries.
PR Contacts
SVM Public Relations
[email protected]
(401) 490-9700
